Company intelligence / Profile preview

DYN’R US

North Miami Beach, Florida, United Statesdynr.com ↗

Ownership: Private
Development stage: Commercial

Overview

DYN'R develops and markets the SDX® System, a respiratory gating device used to manage patient breathing during imaging and radiation therapy. The system is designed to improve the accuracy of tumor targeting by compensating for respiratory motion, particularly in thoracic and abdominal cancers. It is commercially available and widely adopted in leading cancer centers globally[1][3][9].

Therapeutic areas: Oncology
Modalities: Device
Industry: Therapeutic Medical Devices

Partnerships

TheraPanacea (distribution partnership for ART-Plan software in the United States)[7]

Beyond the preview

Go deeper on DYN’R US.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on DYN’R US.

Explore the full profile